Home
Posts
Pfizer Cut the Price of Certain Forms of Ibrance, Its Blockbuster Breast Cancer Med

Pfizer Cut the Price of Certain Forms of Ibrance, Its Blockbuster Breast Cancer Med

And a survey of community oncologists finds near unanimity on the negative impacts of step therapy

Feb 11, 2026

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.